| Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer. | sarcoma,colorectal, |
| Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. | lung, |
| Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma. | sarcoma,kidney, |
| Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population. | bladder, |
| Mutation of oncogene K-ras at codon 12 and codon 13 is a common molecular event in colorectal carcinogenesis, which might be related with age and tumor location. | colorectal, |
| [K-ras gene mutation in colorectal cancer and its clinicopathologic significance]. | colorectal, |
| Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis. | lung, |
| Data show distinct significant correlations between TITF-1 protein expression and DNA copy gain with mutations in the lung adenocarcinoma-prevalent EGFR and KRAS oncogenes. | lung, |
| The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells. | pancreatic, |
| Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy. | lung, |
| stable knockdown of oncogenic KRAS led to inhibition of in vitro and in vivo tumor growth in the KRAS-mutant NSCLC cells | lung, |
| Studies indicate that the function of PKCdelta in tumor cells depends on a specific oncogenic context, as loss of PKCdelta in NSCLC cells suppressed transformed growth only in cells dependent on oncogenic K-ras for proliferation and survival. | lung, |
| Protein kinase C delta is a downstream effector of oncogenic K-ras in lung tumors. | lung, |
| Acute sensitivity of the oral mucosa to oncogenic K-ras. | oral |
| NF-kappaB activation is a novel target of oncogenic KRAS in endometrial carcinogenesis | endometrial, |
| c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. | lung, |
| Elevated expression of ETS-1 gene in a metastatic, tumorigenic human prostate epithelial cell line transformed by the v-Ki-ras oncogene. | prostate, |
| Point mutation of the c-Ki-ras proto-oncogene and the p53 tumour suppressor gene in distal colonic adenocarcinomas. | colorectal, |
| Mutational activation of k-ras oncogene in human breast-tumors. | breast, |
| Relative expression of wild-type and activated ki-ras2 oncogene in colorectal carcinomas. | colorectal, |